Season's greetings 2024
Dear partners and friends,
2024 has been an extraordinary year for Adamant Health. We have continued to educate the market about the benefits of objectively measuring Parkinson’s disease motor symptoms and spread the word about our unique, research-based data-analysis technology, providing detailed and accurate motor symptom data – essential for supporting personalized treatment that can be continuously optimized.
Adamant Health has actively participated in the major events for movement disorders and neurological diseases in Finland and Germany, as well as European-wide at the 10th Congress of the European Academy of Neurology. During this year’s events, we have seen a clear call to evolve the way Parkinson’s disease is diagnosed and treated. Clinical assessment will continue to be essential in the diagnosis and treatment of the disease, but also modern technology, including wearable devices and artificial intelligence, will play a crucial role in the early detection of symptoms and improving treatment effectiveness.
In 2024, we have been developing our measurement equipment and software application, making our service even easier to use for healthcare professionals and the measurement device more comfortable to wear for patients. We have also released a new patient diary, particularly developed for people with Parkinson’s disease, offering an easy and secure way to collect accurate information on the patient's medication intakes, symptoms, and well-being for clinical use.
The cooperation with our customers in Finland and Germany continued during 2024, and we are proud to share Paracelsus Nordseeklinik Helgoland’s experience using our service.
Adamant Health has been selected for the 2024 US MedTech program in the Nordic Mentor Network For Entrepreneurship and the Business Finland AMPlify – Accelerated US Market Entry program 2024 in collaboration with Mayo Clinic, which will support us in the preparations for a successful entry into the US market.
To serve our customers better and continuously develop our service, we have strengthened our team, and we are now 17 professionals dedicated to revolutionizing the care of Parkinson's disease!
As the year draws to a close, we’d like to thank you for your cooperation and support throughout the year. As we pause to spend time with family and friends during the holidays, we wish you a happy, healthy holiday season and a wonderful New Year!
For 2025, we invite you to join us in embracing the future of data-driven Parkinson’s disease management. By leveraging advanced technology and objective measurement methods, we can enhance patient outcomes, improve the patient’s quality of life, and drive progress in Parkinson’s disease research and treatment.
The Adamant Health team